Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1998
12/10/1998WO1998055490A1 Novel class of nucleic acid cationic transfecting agents
12/10/1998WO1998055150A1 Txu-7-pap immunotoxin and use thereof
12/10/1998WO1998055149A1 Use of drug carriers for producing lymphnode migrating drugs
12/10/1998WO1998055148A1 Pharmaceutical compositions comprising cyclodextrins
12/10/1998WO1998055147A2 Reversible geling co-polymer and method of making
12/10/1998WO1998055122A1 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
12/10/1998WO1998055113A1 Semisolid pharmaceutical formulation containing dexketoprofen trometamol
12/10/1998WO1998055108A1 Device and methods for wound treatment
12/10/1998WO1998055107A1 Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
12/10/1998WO1998055106A1 Method for preparing pharmaceutical formulation
12/10/1998WO1998055105A1 Fibrinogen-coated microspheres
12/10/1998WO1998055103A1 Anti-tumoral therapy agent
12/10/1998WO1998055102A1 Microcrystalline cellulose: alginate pharmaceutical suspensions
12/10/1998WO1998055101A1 Implants for controlled release of pharmaceutically active principles and method for making same
12/10/1998WO1998041188A3 Stable particle in liquid formulations
12/10/1998WO1998039465A3 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
12/10/1998WO1998014216A3 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
12/10/1998DE19724796A1 Mittel zur Antitumortherapie Means for antitumor therapy
12/10/1998DE19723895A1 Bioabbaubare Polyesterurethane, Verfahren zu ihrer Herstellung sowie ihre Verwendung Biodegradable polyester urethanes, processes for their preparation and their use
12/10/1998DE19723807A1 Verfahren zur Herstellung von Copolyestern A process for preparing copolyesters
12/10/1998CA2333352A1 Composition comprising 5-¬4-¬2-(n-methyl-n-2-pyridyl)amino)ethoxy|benzyl|thiazolidine-2,4-dione
12/10/1998CA2294494A1 Fibrinogen-coated microspheres
12/10/1998CA2292837A1 Novel class of nucleic acid cationic transfecting agents
12/10/1998CA2292564A1 Biodegradable polyester urethanes, method for the production and use thereof
12/10/1998CA2292506A1 Pharmaceutical compositions comprising cyclodextrins
12/10/1998CA2292426A1 Txu-7-pap immunotoxin and use thereof
12/10/1998CA2291719A1 Microcrystalline cellulose: alginate pharmaceutical suspensions
12/10/1998CA2291659A1 Implants for controlled release of pharmaceutically active principles and method for making same
12/09/1998EP0882448A1 Method of encapsulating biologically active agents within erythrocytes and apparatus therefor
12/09/1998EP0882139A1 Biologically-active polymers
12/09/1998EP0881915A1 Improvements in or relating to contrast agents
12/09/1998EP0881910A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
12/09/1998EP0881906A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/09/1998EP0881905A1 Urogenital and intestinal disorder compositions comprising a substance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
12/09/1998EP0881899A2 Dosage form of ibuprofen
12/09/1998EP0881891A1 Male contraceptive implant
12/09/1998EP0776338B1 Immunoconjugates comprising tyrosine kinase inhibitors
12/09/1998EP0636028A4 Self-assembling polynucleotide delivery system.
12/09/1998EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998CN1201397A Improved prescription for steroid compound administration
12/09/1998CN1201394A Stabilizing formulation for NGF
12/09/1998CN1201387A Lyophilized thioxanthenone anti-tumor angents
12/09/1998CN1201386A Microemlsions used as carriers for administration of active compounds
12/09/1998CN1201385A Therapeutic preparation for transdermal administration of active substances
12/09/1998CN1201384A Aerosol compositions
12/09/1998CN1201369A Stimulation of cell-mediated immune responses by targeted particulated genetic immunization
12/09/1998CN1200942A Interferon liposome jellies
12/09/1998CN1200924A Fluoxetine enteric micropills
12/08/1998US5847206 Amphiphilic fluorine derivatives with telomeric structures; preparation procedure and biomedical applications
12/08/1998US5847121 Production of nitro-benzyl-dota via direct peptide cyclization
12/08/1998US5847108 Clathrate of isoflavone derivatives and edible composition comprising the same
12/08/1998US5847081 Conjugate vaccine for group B Streptococcus
12/08/1998US5847047 Antimicrobial composition of a polymer and a peptide forming amphiphilic helices of the magainin-type
12/08/1998US5847023 Thermal irreversible gel corneal contact lens formed in situ
12/08/1998US5847009 Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
12/08/1998US5846998 Use of phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferation
12/08/1998US5846996 Topical ascorbic acid compositions
12/08/1998US5846983 Colonic delivery of nicotine to treat inflammatory bowel disease
12/08/1998US5846954 Cyclodextrin compounds and methods of making and use thereof
12/08/1998US5846952 Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery
12/08/1998US5846951 Pharmaceutical compositions
12/08/1998US5846930 Therapeutic human albumin having a low aluminium binding capacity
12/08/1998US5846746 Antibody to ocular and vaginal surface epithelium
12/08/1998US5846741 Boron neutron capture therapy using pre-targeting methods
12/08/1998US5846568 Directly compressible lactitol and method
12/08/1998US5846567 Clot dissolving method
12/08/1998US5846566 Microcapsules for the controlled release of acetylsalicylic acid in the gastrointestinal environment
12/08/1998US5846565 Controlled local delivery of chemotherapeutic agents for treating solid tumors
12/08/1998US5846564 Effervescent composition containing iodinated polyvinylpyrrolidone, and use thereof for disinfection
12/08/1998US5846563 Sustained release heterodisperse hydrogel systems for insoluble drugs
12/08/1998US5846545 Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
12/08/1998US5846537 Modified avidin and streptavidin and methods of use thereof
12/08/1998US5846530 Macrocapsules prepared from crosslinkable polysaccharides, polycations and/or lipids and uses therefor
12/08/1998US5846525 Protected biopolymers for oral administration and methods of using same
12/08/1998US5846521 Pressurized solvent-free drug aerosol compositions containing hydrofluorocarbon propellants
12/08/1998US5846458 Inhibition adsorption of proteins on the liposome surface
12/08/1998CA2108330C Enhancer for the antianemia effect of erythropoietin and method of augmenting the antianemia effect of erythropoietin
12/08/1998CA2073180C Therapeutic uses of melanin
12/08/1998CA2042289C Taste masking and sustained release coatings for pharmaceuticals
12/08/1998CA2038935C Biologically active drug polymer derivatives and method for preparing same
12/08/1998CA1340171C Aqueous solution conataing fat-soluble vitamin k
12/03/1998WO1998053863A2 Composition and methods for transdermal delivery of acid labile drugs
12/03/1998WO1998053847A1 Transdermal delivery system
12/03/1998WO1998053844A1 Pharmaceutical compostions of peptides having low solubility in physiological medium
12/03/1998WO1998053837A1 COMPOSITIONS SUITABLE FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS
12/03/1998WO1998053810A1 Pharmaceutical injection solution containing taxol
12/03/1998WO1998053808A1 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract
12/03/1998WO1998053805A1 Clear, injectable formulation of an anesthetic compound
12/03/1998WO1998053804A1 Methods and compositions for targeting compounds to muscle
12/03/1998WO1998053803A1 Pharmaceutical formulation of omeprazole
12/03/1998WO1998053802A1 Multi-layered osmotic device
12/03/1998WO1998053801A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998WO1998053800A1 Compositions and methods for preventing adhesion
12/03/1998WO1998053698A1 Uses of oil bodies
12/03/1998DE19722831A1 New vehicle system comprising stable, ternary mixed micelles
12/03/1998CA2528646A1 Solid pharmaceutical preparation
12/03/1998CA2291839A1 Conjugated peptide nucleic acids having enhanced cellular uptake
12/03/1998CA2291765A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
12/03/1998CA2291261A1 Clear, injectable formulation of an anesthetic compound
12/02/1998EP0880969A1 Pharmaceutical compositions of peptides having low solubility in physiological medium
1 ... 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 ... 1712